FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789593042> ?p ?o ?g. }

• W2789593042 endingPage "965" @default.
• W2789593042 startingPage "956" @default.
• W2789593042 abstract "Radiotherapy induces anti-tumor immunity by induction of tumor antigens and damage-associated molecular patterns (DAMP). DNA, a representative DAMP in radiotherapy, activates the stimulator of interferon genes (STING) pathway which enhances the immune response. However, the immune response does not always parallel the inflammation associated with radiotherapy. This lack of correspondence may, in part, explain the radiation-resistance of tumors. Additive immunotherapy is expected to revive tumor-specific CTL facilitating radiation-resistant tumor shrinkage. Herein pre-administration of the double-stranded RNA, polyinosinic-polycytidylic acid (polyI:C), in conjunction with radiotherapy, was shown to foster tumor suppression in mice bearing radioresistant, ovalbumin-expressing Lewis lung carcinoma (LLC). Extrinsic injection of tumor antigen was not required for tumor suppression. No STING- and CTL-response was induced by radiation in the implant tumor. PolyI:C was more effective for induction of tumor growth retardation at 1 day before radiation than at post-treatment. PolyI:C targeted Toll-like receptor 3 with minimal effect on the mitochondrial antiviral-signaling protein pathway. Likewise, the STING pathway barely contributed to LLC tumor suppression. PolyI:C primed antigen-presenting dendritic cells in draining lymph nodes to induce proliferation of antigen-specific CTL. By combination therapy, CTL efficiently infiltrated into tumors with upregulation of relevant chemokine transcripts. Batf3-positive DC and CD8+ T cells were essential for therapeutic efficacy. Furthermore, polyI:C was shown to stimulate tumor-associated macrophages and release tumor necrosis factor alpha, which acted on tumor cells and increased sensitivity to radiation. Hence, polyI:C treatment prior to radiotherapy potentially induces tumor suppression by boosting CTL-dependent and macrophage-mediated anti-tumor responses. Eventually, polyI:C and radiotherapy in combination would be a promising therapeutic strategy for radiation-resistant tumors." @default.
• W2789593042 created "2018-03-29" @default.
• W2789593042 creator A5002317398 @default.
• W2789593042 creator A5009824094 @default.
• W2789593042 creator A5010637386 @default.
• W2789593042 creator A5013481435 @default.
• W2789593042 creator A5020774876 @default.
• W2789593042 creator A5034750109 @default.
• W2789593042 creator A5071402791 @default.
• W2789593042 creator A5089860635 @default.
• W2789593042 creator A5090622398 @default.
• W2789593042 date "2018-03-25" @default.
• W2789593042 modified "2023-10-16" @default.
• W2789593042 title "Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model" @default.
• W2789593042 cites W1129892654 @default.
• W2789593042 cites W1603862958 @default.
• W2789593042 cites W1611944043 @default.
• W2789593042 cites W1974078879 @default.
• W2789593042 cites W1994826332 @default.
• W2789593042 cites W1997069349 @default.
• W2789593042 cites W2003601710 @default.
• W2789593042 cites W2013107562 @default.
• W2789593042 cites W2013601771 @default.
• W2789593042 cites W2016268206 @default.
• W2789593042 cites W2024309898 @default.
• W2789593042 cites W2028575270 @default.
• W2789593042 cites W2029339804 @default.
• W2789593042 cites W2042173485 @default.
• W2789593042 cites W2043793366 @default.
• W2789593042 cites W2050216284 @default.
• W2789593042 cites W2055132644 @default.
• W2789593042 cites W2062254683 @default.
• W2789593042 cites W2073115216 @default.
• W2789593042 cites W2077355453 @default.
• W2789593042 cites W2090994296 @default.
• W2789593042 cites W2092021793 @default.
• W2789593042 cites W2095007033 @default.
• W2789593042 cites W2098579403 @default.
• W2789593042 cites W2100143031 @default.
• W2789593042 cites W2107860814 @default.
• W2789593042 cites W2108789863 @default.
• W2789593042 cites W2112002812 @default.
• W2789593042 cites W2123894372 @default.
• W2789593042 cites W2132127444 @default.
• W2789593042 cites W2154203858 @default.
• W2789593042 cites W2154478576 @default.
• W2789593042 cites W2158582298 @default.
• W2789593042 cites W2161702641 @default.
• W2789593042 cites W2165365045 @default.
• W2789593042 cites W2168401979 @default.
• W2789593042 cites W2171010115 @default.
• W2789593042 cites W2177971463 @default.
• W2789593042 cites W2266683146 @default.
• W2789593042 cites W2404729303 @default.
• W2789593042 cites W2461271870 @default.
• W2789593042 cites W2516091650 @default.
• W2789593042 cites W2520382278 @default.
• W2789593042 cites W2580642001 @default.
• W2789593042 cites W2617823945 @default.
• W2789593042 cites W4293529598 @default.
• W2789593042 doi "https://doi.org/10.1111/cas.13543" @default.
• W2789593042 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5891207" @default.
• W2789593042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29465830" @default.
• W2789593042 hasPublicationYear "2018" @default.
• W2789593042 type Work @default.
• W2789593042 sameAs 2789593042 @default.
• W2789593042 citedByCount "22" @default.
• W2789593042 countsByYear W27895930422019 @default.
• W2789593042 countsByYear W27895930422020 @default.
• W2789593042 countsByYear W27895930422021 @default.
• W2789593042 countsByYear W27895930422022 @default.
• W2789593042 countsByYear W27895930422023 @default.
• W2789593042 crossrefType "journal-article" @default.
• W2789593042 hasAuthorship W2789593042A5002317398 @default.
• W2789593042 hasAuthorship W2789593042A5009824094 @default.
• W2789593042 hasAuthorship W2789593042A5010637386 @default.
• W2789593042 hasAuthorship W2789593042A5013481435 @default.
• W2789593042 hasAuthorship W2789593042A5020774876 @default.
• W2789593042 hasAuthorship W2789593042A5034750109 @default.
• W2789593042 hasAuthorship W2789593042A5071402791 @default.
• W2789593042 hasAuthorship W2789593042A5089860635 @default.
• W2789593042 hasAuthorship W2789593042A5090622398 @default.
• W2789593042 hasBestOaLocation W27895930421 @default.
• W2789593042 hasConcept C126322002 @default.
• W2789593042 hasConcept C134018914 @default.
• W2789593042 hasConcept C136449434 @default.
• W2789593042 hasConcept C170493617 @default.
• W2789593042 hasConcept C185592680 @default.
• W2789593042 hasConcept C2776709828 @default.
• W2789593042 hasConcept C502942594 @default.
• W2789593042 hasConcept C71924100 @default.
• W2789593042 hasConcept C86803240 @default.
• W2789593042 hasConcept C95444343 @default.
• W2789593042 hasConceptScore W2789593042C126322002 @default.
• W2789593042 hasConceptScore W2789593042C134018914 @default.
• W2789593042 hasConceptScore W2789593042C136449434 @default.
• W2789593042 hasConceptScore W2789593042C170493617 @default.
• W2789593042 hasConceptScore W2789593042C185592680 @default.

• next